Contact

Please select a country

us@pharmalex.com

Contact United States

TwitterLinkedin
contact@pharmalex.com
  • News & Events
    • News
    • Webinars
    • Events
Top Bar
Search
PharmaLexPharmaLex
PharmaLex
Confidence Beyond Compliance
  • About Us
    • About Us
    • Management Team
    • Industry Expertise
      • Biopharma
      • Customer On-site Support
      • Portfolio Maintenance Outsourcing
      • Medical Device Services
    • What Our Clients Say About Us
    • Our Approach
    • Resource Library
  • Our Services
    • Choose a Service
    • InnoPHLEX
    • SourcePHLEX
    • SmartPHLEX
    • Development Consulting
    • Regulatory Affairs
    • Quality Management & Compliance
    • Pharmacovigilance, Epidemiology & Risk Management
    • Medical Device Services
    • Brexit
  • Countries
  • Contact us
  • Careers
    • Current Opportunities
    • Why work at PharmaLex
    • Working at PharmaLex
  • Training
Menu back  
Home > News & Events > France > December 1st, 2016: Celebrating PharmaLex expansion with office opening in Paris, France.

December 1st, 2016: Celebrating PharmaLex expansion with office opening in Paris, France.

Thanks to the support of our valued customers and partners PharmaLex has been expanding rapidly worldwide. Since the beginning of December 2016, the new PharmaLex office located in the west of Paris is home to our French affiliate. The new office is headed by Ms. Sophie Guillaume, General Manager PharmaLex France, and Mr. Patrick Larcier, Senior Director Drug Development and Vigilance. To celebrate the opening, we held an evening launch party on the 1st of December. Over 80 guests from the pharmaceutical and biotech industry came along for drinks, canapés and to use the opportunity to find out more on PharmaLex’s global service offerings as well as the Paris office local services. PharmaLex combines local expertise with global reach in the area of development consulting, scientific affairs, regulatory affairs and pharmacovigilance. A proven track record of success in outsourcing programs with more than 25,000 successfully completed projects for over 550 clients worldwide. We offer extensive experience in all therapeutic areas & product groups, including advanced therapy medicinal products & biopharmaceuticals, medical & borderline products as well as alternative therapeutic approaches.

It was really nice to see so many of the people that have helped our recent growth efforts and to have the opportunity to chat, socialize and network with current and also new potential customers. We are very proud of how far PharmaLex has come during the last years. The impact our subject matter experts have made in helping companies worldwide in development consulting, regulatory affairs as well as vigilance compliance services has been great. Our new office in France marks the next stage in our development and we look forward to continuing our growth at an even faster rate within our worldwide PharmaLex offices.

 

For further information, please contact:

Ms. Eva Keck
PharmaLex GmbH; Director Business Development Operations
eva.keck@pharmalex.com
+49 621 18 15 38 0
Harrlachweg 6; 68163 Mannheim
Germany

About PharmaLex
Related posts
PharmaLex to plant 250 trees to celebrate its 25th anniversary
9th December 2019
Our 25th Biosimilar Molecule in Our 25th Year!
3rd December 2019
DIA RSIDM 2020
3rd December 2019
DIA Europe 2020
3rd December 2019
The shift in responsibility for determining IR35 compliance: How will it affect regulatory staffing in the UK?
27th November 2019
Objectives: New EU Medical Device and In-Vitro Diagnostic Regulations
25th November 2019
Search
Recent News
  • Brexit Checklist for the Pharma Industry
    26th February 2019
  • PharmaLex to plant 250 trees to celebrate its 25th anniversary
    9th December 2019
  • Our 25th Biosimilar Molecule in Our 25th Year!
    3rd December 2019
  • The shift in responsibility for determining IR35 compliance: How will it affect regulatory staffing in the UK?
    27th November 2019
  • Objectives: New EU Medical Device and In-Vitro Diagnostic Regulations
    25th November 2019
  • EMA guidance on biosimilars in the EU
    25th November 2019
  • PharmaLex Internal Audit Programme Management Services
    14th November 2019
Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
  • Careers // PharmaLex is currently hiring in various locations across the globe! Visit our careers page to view curr… https://t.co/e5v7IDAZzv11 days ago
  • Career // PharmaLex is currently hiring in various locations across the globe! Visit our career page to view curren… https://t.co/JZJCTzcS8Z25 days ago
NEWSLETTER SIGN UP



View our privacy policy

WHAT OUR CLIENTS SAY
  • PharmaLex is dedicated to delivering a comprehensive portfolio while their modular approach allows tailor-made solutions. They acknowledge our feedback, modify their approach and adapt accordingly.

    Top 10 Pharma Company
    President
PharmaLex
©2019 PharmaLex GmbH. All rights reserved.

Privacy Policy

This can be specific information about signing up to the newsletter.

Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. These emails are being sent from @pharmalexcompanies.com and are not from us. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.